Oncotelic Therapeutics, Inc. (OTCQB: OTLC) announced the launch of its artificial intelligence-powered good manufacturing practices (GMP) manufacturing services platform at the 2026 BIO International Convention in San Diego. The platform integrates the company’s PDAOAI technology with advanced robotics provided through its collaboration with TechForce Robotics, targeting pharmaceutical, biotechnology and advanced therapeutics companies seeking to modernize manufacturing operations.
The platform is designed to support electronic batch records, manufacturing documentation, GMP workflow digitization, quality and compliance functions and process monitoring. By combining AI-driven workflows with intelligent automation, Oncotelic aims to reduce human error, increase efficiency and accelerate production timelines for complex therapeutics.
In addition to the platform launch, Oncotelic will showcase progress with its Deciparticle nanomedicine platform, including SAPU003, a clinical-stage intravenous everolimus program currently being evaluated in a Phase 1b study. The company positions these developments as part of its broader mission to address high-unmet-need cancers and rare pediatric indications.
Oncotelic’s CEO, Dr. Vuong Trieu, has filed over 500 patent applications and holds 75 issued U.S. patents. The company also owns 45% of GMP Bio, a joint venture that advances its own pipeline of drug candidates. Through Oncotelic’s relationship with SAPU Bio, an OEB-5 sterile injectable cGMP manufacturing facility, PDAOAI underpins the platform and ongoing joint development work with TechForce Robotics.
TechForce Robotics, the operating brand of Nightfood Holdings, Inc., designs and deploys purpose-built robotics and automation solutions for service, hospitality and pharmaceutical manufacturing applications. The collaboration with Oncotelic aims to bring robotics expertise to the pharmaceutical manufacturing sector.
For more information about Oncotelic Therapeutics, visit www.oncotelic.com. For details on TechForce Robotics, visit www.techforcerobotics.com. The full press release is available at https://ibn.fm/upnBW.
